Stay updated on CPIT001 Clinical Trial
Sign up to get notified when there's something new on the CPIT001 Clinical Trial page.

Latest updates to the CPIT001 Clinical Trial page
- ChecktodayChange DetectedThe page has undergone significant changes with the removal of three important medical studies related to Nivolumab and Ipilimumab in melanoma treatment, while the same studies have been added back without the erratum notes.SummaryDifference0.7%
- Check8 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.0%
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedThe page has undergone significant content removal, particularly regarding the detailed description of a clinical study on combined checkpoint inhibition after autologous hematopoietic stem cell transplantation for high-risk patients. The only notable addition is the mention of 'Multiple Myeloma' and a revision number update.SummaryDifference36%
- Check29 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.0%
- Check37 days agoChange DetectedThe page has been updated to include information on Multiple Myeloma and has been revised to version 2.14.3, while references to Lymphosarcoma and the previous version 2.14.2 have been removed.SummaryDifference0.1%
- Check51 days agoChange DetectedDifference0.1%
Stay in the know with updates to CPIT001 Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CPIT001 Clinical Trial page.